β-Blockers improve outcomes in kidney disease patients having noncardiac vascular surgery
- 1 December 2007
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 72 (12) , 1527-1534
- https://doi.org/10.1038/sj.ki.5002554
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Kidney Function and Risk of Peripheral Arterial DiseaseJournal of the American Society of Nephrology, 2007
- Beta blockers in the management of chronic kidney diseaseKidney International, 2006
- β2-Adrenergic Receptor Genotype and Survival Among Patients Receiving β-Blocker Therapy After an Acute Coronary SyndromeJAMA, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care OrganizationArchives of internal medicine (1960), 2004
- Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathyJournal of the American College of Cardiology, 2003
- The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular SurgeryNew England Journal of Medicine, 1999
- Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobinAmerican Journal of Kidney Diseases, 1999
- Neural contribution to renal hypertension following acute renal artery stenosis in conscious rats.Hypertension, 1983
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976